Federal Cannabis Law and Policy in 2026
Marijuana Rescheduling, Hemp Reform, and What Comes Next
Join Harris Sliwoski attorneys Jason Adelstone and Vince Sliwoski for a timely, practical discussion of what these changes mean—and what to expect as federal agencies and regulators begin implementation.
U.S. federal cannabis law is at a critical inflection point. In 2026, two major federal developments are poised to reshape the legal and business landscape:
-
The President’s recent Executive Order directing the rescheduling of marijuana from Schedule I to Schedule III under the Controlled Substances Act
- New Congressional legislation redefining “hemp,” with significant implications for intoxicating hemp products, effective this November
In this webinar, we covered:
-
How marijuana rescheduling could affect taxation (including IRC Section 280E), research, and access to service providers
-
Whether rescheduling creates a viable federal pathway for full-spectrum CBD products
-
The likely impact of the new federal prohibition on intoxicating hemp products
-
Key legal uncertainties, enforcement risks, and upcoming rulemaking
- How different categories of operators may be helped—or harmed—in 2026
This webinar is designed to help attendees understand near-term risks and opportunities and begin preparing for a rapidly evolving federal framework.